Chunxiang Fan

National Key Laboratory Of Intelligent Tracking And Forecasting For Infectious Diseases
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Adverse events following immunization with human papillomavirus vaccine: post-marketing surveillance in China, 2021-2024.

Adverse events following immunization with human papillomavirus vaccine: post-marketing surveillance in China, 2021-2024.

Journal: Vaccine
Published: April 27, 2026

Post-Marketing Surveillance of Adverse Events Following 23-Valent Pneumococcal Polysaccharide Vaccination - China, 2021-2024.

Post-Marketing Surveillance of Adverse Events Following 23-Valent Pneumococcal Polysaccharide Vaccination - China, 2021-2024.

Journal: China CDC weekly
Published: April 15, 2026

Post-Marketing Surveillance Data of Adverse Events Following Immunization with Human Rabies Vaccine - China, 2021-2024.

Post-Marketing Surveillance Data of Adverse Events Following Immunization with Human Rabies Vaccine - China, 2021-2024.

Journal: China CDC weekly
Published: January 04, 2026

Post-marketing surveillance of adverse events following enterovirus type 71 inactivated vaccine in China, 2016-2023.

Post-marketing surveillance of adverse events following enterovirus type 71 inactivated vaccine in China, 2016-2023.

Journal: Vaccine
Published: October 14, 2025

Post-Marketing Surveillance of Adverse Events Following Rotavirus Vaccination - China, 2013-2023.

Post-Marketing Surveillance of Adverse Events Following Rotavirus Vaccination - China, 2013-2023.

Journal: China CDC weekly
Published: March 25, 2025

Post-Marketing Surveillance of Adverse Events Following Recombinant Zoster Vaccine - China, 2020-2023.

Post-Marketing Surveillance of Adverse Events Following Recombinant Zoster Vaccine - China, 2020-2023.

Journal: China CDC weekly
Published: March 24, 2025

Minimum Data Set and Metadata for Active Vaccine Safety Surveillance: Systematic Review.

Minimum Data Set and Metadata for Active Vaccine Safety Surveillance: Systematic Review.

Journal: JMIR public health and surveillance
Published: June 12, 2024

Post-Marketing Surveillance of Adverse Events Following Immunization with Haemophilus Influenzae Type b Conjugate Vaccine - China, 2010-2021.

Post-Marketing Surveillance of Adverse Events Following Immunization with Haemophilus Influenzae Type b Conjugate Vaccine - China, 2010-2021.

Journal: China CDC weekly
Published: April 03, 2024

Surveillance for Adverse Events Following Immunization with Domestic Sabin-Strain Inactivated Poliovirus Vaccine - China, 2015-2022.

Surveillance for Adverse Events Following Immunization with Domestic Sabin-Strain Inactivated Poliovirus Vaccine - China, 2015-2022.

Journal: China CDC weekly
Published: March 19, 2024

Post-Marketing Surveillance of Adverse Events Following Meningococcal Vaccination - China, 2013-2021.

Post-Marketing Surveillance of Adverse Events Following Meningococcal Vaccination - China, 2013-2021.

Journal: China CDC weekly
Published: March 04, 2024

Risk Assessments for Type 1 Wild Poliovirus and Type 2 Vaccine-Derived Poliovirus Importation and Transmission - China, 2023.

Risk Assessments for Type 1 Wild Poliovirus and Type 2 Vaccine-Derived Poliovirus Importation and Transmission - China, 2023.

Journal: China CDC weekly
Published: January 20, 2024

Thirty Years of Experience of Acute Flaccid Paralysis Surveillance for Polio - China, 1993-2022.

Thirty Years of Experience of Acute Flaccid Paralysis Surveillance for Polio - China, 1993-2022.

Journal: China CDC weekly
Published: December 06, 2023
Showing 1-12 of 26

Last Updated: 09/26/2026